Eli Lilly vs. Novo Nordisk: Who Leads the $100 Billion Obesity Market?

An analysis compares Eli Lilly and Company (LLY) and Novo Nordisk A/S (NVO) to determine which pharmaceutical giant is gaining an advantage in the rapidly expanding $100 billion obesity drug market.